A) Inhibition of protein synthesis B) Inhibition of DNA replication C) Inhibition of cell wall synthesis D) Disruption of cell membrane integrity
A) Nucleoid region B) Cell membrane lipids C) Peptidoglycan layer of bacterial cell walls D) Ribosomes
A) Transport nutrients across the cell membrane B) Synthesize nucleic acids C) Generate energy for the cell D) Facilitate the final transpeptidation step in peptidoglycan synthesis
A) Lipoproteins B) DNA polymerases C) Penicillin binding proteins (PBPs) D) Ribosomal proteins
A) Facilitates their binding to the active site of PBPs B) Helps them to bind to DNA C) Allows them to penetrate the bacterial cell membrane D) Enables them to inhibit ribosomal function
A) Arg75 B) Ser62 C) Glu100 D) Lys50
A) Activation of bacterial DNA replication B) Stimulation of bacterial cell division C) Enhancement of peptidoglycan synthesis D) Prevention of the final crosslinking of the peptidoglycan layer
A) Bacteria, including cyanobacteria, cyanelles, and chloroplasts of bryophytes B) Vascular plants C) Fungi D) Viruses
A) Induction of cell death B) No effect C) Inhibition of division D) Disruption of photosynthesis
A) Endosymbiotic theory B) Germ theory of disease C) Theory of spontaneous generation D) Cell theory
A) Presence of β-lactam antibiotics B) High temperature C) Absence of nutrients D) Build-up of peptidoglycan precursors
A) By causing the digestion of existing peptidoglycan without new production B) By inhibiting bacterial DNA replication C) By increasing bacterial cell wall synthesis D) By promoting bacterial cell division
A) Methicillin-resistant enzyme B) Penicillinase C) β-lactamase D) Aminoglycoside acetyltransferase
A) Protease inhibitors B) Reverse transcriptase inhibitors C) β-lactamase inhibitors such as clavulanic acid D) Integrase inhibitors
A) Hypertension B) Hyperglycemia C) Bradycardia D) Diarrhea
A) Approximately 15% B) Approximately 2% or less C) Approximately 10% D) Approximately 5%
A) Approximately 5% B) Approximately 10% C) Less than 1% D) Approximately 15%
A) Anaphylactic reaction B) Jarisch–Herxheimer reaction C) Serum sickness D) Tzanck reaction
A) The molecular weight of the β-lactam antibiotic B) The solubility of the β-lactam antibiotic C) Cohen's parameter (c) D) Woodward's parameter (h)
A) Woodward's parameter (h) B) The solubility of the β-lactam antibiotic C) Cohen's parameter (c) D) The molecular weight of the β-lactam antibiotic
A) Zero h values B) Lower h values C) Higher h values D) Constant h values
A) Zero c values B) Higher c values C) Lower c values D) Constant c values
A) 8-oxo-2'-deoxyguanosine lesions B) Double-strand breaks C) Thymine dimers D) Single-strand breaks
A) A hydroxyl group B) A carboxylate group C) A β-lactam ring D) An amide bond
A) Ceftriaxone/meropenem B) Amoxicillin/clavulanic acid C) Ceftriaxone/nitrocefin D) Piperacillin/tazobactam
A) A hydroxyl group B) A β-lactamase inhibitor C) An auxiliary ring with a carboxylate group D) An amide bond
A) Meropenem B) Amoxicillin C) Clavulanic acid D) Ceftriaxone
A) It influences the antibiotic's solubility B) It is essential for the antibiotic's antimicrobial activity C) It determines the antibiotic's color D) It affects the antibiotic's taste
A) Penems B) Oxapenams C) Penams D) Carbapenams
A) Nonribosomal peptide synthetase B) Isopenicillin N synthase (IPNS) C) β-lactam synthetase D) ACV synthetase (ACVS)
A) Carbapenem B) Monobactam C) Cephem D) Isopenicillin N
A) ACV synthetase (ACVS) B) Isopenicillin N synthase (IPNS) C) Nonribosomal peptide synthetase D) β-lactam synthetase
A) Position 5 B) Position 3 C) Position 4 D) Position 1
A) Penems B) Cephems C) Monobactams D) Carbapenems
A) Cephems B) Carbapenems C) Monobactams D) Penams
A) Oxacephems B) Cephems C) Monobactams D) Carbacephems
A) Monobactams B) Cephems C) Oxacephems D) Carbacephems
A) Penems B) Monobactams C) Carbapenems D) Cephems
A) Cephems B) Carbacephems C) Monobactams D) Oxacephems
A) Carbapenams B) Penams C) Oxapenams D) Penems |